Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Saturday
May 25th
Home
Innovative Medicine Demand
Innovative Arthritis Medicine

osteoarthritis_rheumatoid_arthritis_by_ilovepiano.jpg

Demand: Innovative Arthritis Medicine

Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis. 

Company is looking to joint-venture, collaborative development or in-licensing of  non-prescrition products, on exclusive basis. 

For more details please contact Farmavita.Net. 

Innovative Medicines Offer
New Joint Health Supplement

Renarthro - Preserving Bone and Joint Health

Renarthro_Brand

Farmavita has developed Renarthro, the synergistic combination of frankincense and myrrh extracts, with Osteol. Renarthro is formulated into capsules, ice-gel and honey.  This unique innovative product is available for exclusive licensing or distributorship, for selected markets.  Product details are available at www.renarthro.com or please send inquiry  to info@farmavita.net.   

 
Generic Medicine Demand
Ciprofloxacin 250 EU

GLOBALPHARMA Estonia is looking to acquire dossiers to produce ciprofloxacin 250 for the EU. 

Please contact with your profile and more info. 

Generic Medicines - Offer
Risedronate 75mg We offer for out-licensing European e-CTD format of Risedronate 75mg and/or Risedronate 35mg f.c. tablets. Dossier is ready and is currently under registration in several EU countries. Preferred model is of business cooperation is License Fee + Supply with finished product.
 
OTC / Nutraceutical Demand
Vaginal Infections

Looking for OTC medications against vaginal infections

Farmavita.Net member is looking for OTC medicatios against vaginal infections. Product should be approved in EU and have up-to-date CTD Dossier. Licensee will also close exclusive supply agreement with licensor.

Examples of suitable products are monoproducts or combinations of fluconazole, itraconacole, clindamycine pessaries and cream, as well as smiilar products.  

API/Technology Demand
SPECTINOMYCIN HCL -COMMERCIAL TECHNOLOGY WANTED

WE REQUIRE PLANT PROVEN COMMERCIAL TECHNOLOGY TO MANAUFACTURE SPECTINOMYCIN HCL IN INDIA . TECHNOLOGY LICENCENSORS/MANUFACTURING COMPANIES/CONSULTANTS TO SUBMIT THEIR TECHNICAL AND COMMERCIAL PROFILE AND BUSINESS TERMS.

 

CONTACT; MR.ARVIND GANDHI -GM MKTG ( API AND FINE CHEMICALS) ASENCE PHARMA PVT.LTD.,MUMBAI.

EMAIL; saramvitc@asedvnsmc.com

 

              

 
Open Innovation
Open Source BioPharma Systems

Open source systems lure drug developers

apple2.jpgThe gradual spread of software automation in drug development may be getting a boost from open source systems. Most e-clinical systems today--from data capture and storage to trial management and operations--are proprietary, despite the excellent work that solutions providers have done to make their products compatible with existing standards-based and de facto standard industry systems.

Life Science Article
Micro- and Nanoscale Technologies

cell.jpg

Micro- and nanoscale technologies for tissue engineering and drug discovery applications

Micro- and nanoscale technologies are emerging as powerful enabling tools for tissue engineering and drug discovery. In tissue engineering, micro- and nanotechnologies can be used to fabricate biomimetic scaffolds with increased complexity and vascularization.

The whole 16 pages article is available for download at Downloads section of Farmavita.Net.   

 
Events
Chemical Sales & Marketing Toolbox

Chemical Sales & Marketing Toolbox

18-19th June, Frankfurt, Germany

ch-150x150-an.gif

The game in the chemical sales and marketing sector has changed over the past couple of years since processes have become faster and competition sharper. Also, as customers are becoming even more influential and empowered in making decisions, the need for change has never been more critical. Only those who adapt to the current challenging chemistry landscape will prove their readiness to compete successfully.

Market Report
Refurbished Medical Devices

 business-insights-logo.gif

The Market Outlook for Refurbished Medical Devices to 2016

This report gives a thorough analysis of the refurbished medical devices market segment. The regulatory environment for refurbished devices is assessed in 92 countries. Opportunities within this market are assessed by device type and by country. A thorough analysis of who the end users for refurbished devices are and what their demands are, with strategies and best practices for growth discussed.

 
Advertisement

Featured Partners

 
logo_kvadrat_150x150.jpg    
lcm-150x150.jpg  
150-150-static.gif
apacma13_150x150_banner.gif  
  doctors20150x1501.png
bals137_150x150.gif
bals138_150x150.jpg
ch-150x150-an.gif 
pharmaccess13a_150x150.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 12 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

150-150-static.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif